Detection of copy number alterations in acute myeloid leukemia and myelodysplastic syndromes

References

• Haase D, Germing U, Schanz J et al. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood110(13), 4385–4395 (2007).
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Thiele J, Arber DA et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood114(5), 937–951 (2009).
   PubMed Web of Science ®Google Scholar
• Greenberg P, Cox C, LeBeau MM et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood89(6), 2079–2088 (1997).
   PubMed Web of Science ®Google Scholar
• Malcovati L, Germing U, Kuendgen A et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J. Clin. Oncol.25(23), 3503–3510 (2007).
   PubMed Web of Science ®Google Scholar
• Dohner H, Estey EH, Amadori S et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European Leukemia Net. Blood115(3), 453–474 (2010).
   PubMed Web of Science ®Google Scholar
• Mardis ER, Ding L, Dooling DJ et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med.361(11), 1058–1066 (2009).
   PubMed Web of Science ®Google Scholar
• Ley TJ, Ding L, Walter MJ et al.DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med.363(25), 2424–2433 (2010).
   PubMed Web of Science ®Google Scholar
• O’Keefe CL, Tiu R, Gondek LP et al. High-resolution genomic arrays facilitate detection of novel cryptic chromosomal lesions in myelodysplastic syndromes. Exp. Hematol.35(2), 240–251 (2007).
   PubMed Web of Science ®Google Scholar
• Paulsson K, Heidenblad M, Strombeck B et al. High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration. Leukemia20(5), 840–846 (2006).
   PubMed Web of Science ®Google Scholar
• Thiel A, Beier M, Ingenhag D et al. Comprehensive array CGH of normal karyotype myelodysplastic syndromes reveals hidden recurrent and individual genomic copy number alterations with prognostic relevance. Leukemia25(3), 387–399 (2011).
   PubMed Web of Science ®Google Scholar
• Starczynowski DT, Vercauteren S, Telenius A et al. High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival. Blood112(8), 3412–3424 (2008).
   PubMed Web of Science ®Google Scholar
• Graubert TA, Payton MA, Shao J et al. Integrated genomic analysis implicates haploinsufficiency of multiple chromosome 5q31.2 genes in de novo myelodysplastic syndromes pathogenesis. PLoS One4(2), e4583 (2009).
   PubMed Web of Science ®Google Scholar
• Suela J, Alvarez S, Cigudosa JC. DNA profiling by arrayCGH in acute myeloid leukemia and myelodysplastic syndromes. Cytogenet Genome Res.118(2–4), 304–309 (2007).
   PubMed Web of Science ®Google Scholar
• Heinrichs S, Look AT. Identification of structural aberrations in cancer by SNP array analysis. Genome Biol.8(7), 219 (2007).
   Google Scholar
• Heinrichs S, Li C, Look AT. SNP array analysis in hematologic malignancies: avoiding false discoveries. Blood115(21), 4157–4161 (2010).
   PubMed Web of Science ®Google Scholar
• O’Keefe C, McDevitt MA, Maciejewski JP. Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies. Blood115(14), 2731–2739 (2010).
   PubMed Web of Science ®Google Scholar
• Delhommeau F, Jeziorowska D, Marzac C, Casadevall N. Molecular aspects of myeloproliferative neoplasms. Int. J. Hematol.91(2), 165–173 (2010).
   PubMed Web of Science ®Google Scholar
• Tiu RV, Visconte V, Traina F, Schwandt A, Maciejewski JP. Updates in cytogenetics and molecular markers in MDS. Curr. Hematol. Malig. Rep.6(2), 126–135 (2011).
   PubMed Web of Science ®Google Scholar
• Mullighan CG, Goorha S, Radtke I et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature446(7137), 758–764 (2007).
   PubMed Web of Science ®Google Scholar
• Mullighan CG, Miller CB, Radtke I et al.BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature453(7191), 110–114 (2008).
   PubMed Web of Science ®Google Scholar
• Mullighan CG, Phillips LA, Su X et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science322(5906), 1377–1380 (2008).
   PubMed Web of Science ®Google Scholar
• Heinrichs S, Kulkarni RV, Bueso-Ramos CE et al. Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics. Leukemia23(9), 1605–1613 (2009).
   PubMed Web of Science ®Google Scholar
• Gondek LP, Haddad AS, O’Keefe CL et al. Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes. Exp. Hematol.35(11), 1728–1738 (2007).
   PubMed Web of Science ®Google Scholar
• Gondek LP, Tiu R, O’Keefe CL, Sekeres MA, Theil KS, Maciejewski JP. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. Blood111(3), 1534–1542 (2008).
   PubMed Web of Science ®Google Scholar
• Mohamedali A, Gaken J, Twine NA et al. Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes. Blood110(9), 3365–3373 (2007).
   PubMed Web of Science ®Google Scholar
• Radtke I, Mullighan CG, Ishii M et al. Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia. Proc. Natl Acad. Sci. USA106(31), 12944–12949 (2009).
   PubMed Web of Science ®Google Scholar
• Tiu RV, Gondek LP, O’Keefe CL et al. Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies. Blood117(17), 4552–4560 (2011).
   PubMed Web of Science ®Google Scholar
• Tyybakinoja A, Elonen E, Piippo K, Porkka K, Knuutila S. Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia. Leukemia21(3), 571–574 (2007).
   PubMed Web of Science ®Google Scholar
• Suela J, Alvarez S, Cifuentes F et al. DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groups. Leukemia21(6), 1224–1231 (2007).
   PubMed Web of Science ®Google Scholar
• Barresi V, Romano A, Musso N et al. Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes. Genes Chromosomes Cancer49(11), 1014–1023 (2010).
   Google Scholar
• Gupta M, Raghavan M, Gale RE et al. Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia. Genes Chromosomes Cancer47(9), 729–739 (2008).
   Google Scholar
• Tiu RV, Gondek LP, O’Keefe CL et al. New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia. J. Clin. Oncol.27(31), 5219–5226 (2009).
   PubMed Web of Science ®Google Scholar
• Walter MJ, Payton JE, Ries RE et al. Acquired copy number alterations in adult acute myeloid leukemia genomes. Proc. Natl Acad. Sci. USA106(31), 12950–12955 (2009).
   PubMed Web of Science ®Google Scholar
• Walter MJ, Shen D, Ding L et al. Clonal architecture of secondary acute myeloid leukemia. N. Engl. J. Med.366(12), 1090–1098 (2012).
   PubMed Web of Science ®Google Scholar
• Solomon DA, Kim T, Diaz-Martinez LA et al. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science333(6045), 1039–1043 (2011).
   PubMed Web of Science ®Google Scholar
• Bullinger L, Kronke J, Schon C et al. Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis. Leukemia24(2), 438–449 (2010).
   PubMed Web of Science ®Google Scholar
• Parkin B, Erba H, Ouillette P et al. Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia. Blood116(23), 4958–4967 (2010).
   PubMed Web of Science ®Google Scholar
• Lorsbach RB, Moore J, Mathew S, Raimondi SC, Mukatira ST, Downing JR. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia17(3), 637–641 (2003).
   PubMed Web of Science ®Google Scholar
• Delhommeau F, Dupont S, Della Valle V et al. Mutation in TET2 in myeloid cancers. N. Engl. J. Med.360(22), 2289–2301 (2009).
   PubMed Web of Science ®Google Scholar
• Langemeijer SM, Kuiper RP, Berends M et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat. Genet.41(7), 838–842 (2009).
   PubMed Web of Science ®Google Scholar
• Mohamedali AM, Smith AE, Gaken J et al. Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome. J. Clin. Oncol.27(24), 4002–4006 (2009).
   PubMedGoogle Scholar
• Jankowska AM, Szpurka H, Tiu RV et al. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. Blood113(25), 6403–6410 (2009).
   PubMed Web of Science ®Google Scholar
• Sanada M, Suzuki T, Shih LY et al. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms. Nature460(7257), 904–908 (2009).
   PubMed Web of Science ®Google Scholar
• Dunbar AJ, Gondek LP, O’Keefe CL et al. 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies. Cancer Res.68(24), 10349–10357 (2008).
   PubMed Web of Science ®Google Scholar
• Makishima H, Cazzolli H, Szpurka H et al. Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies. J. Clin. Oncol.27(36), 6109–6116 (2009).
   PubMed Web of Science ®Google Scholar
• Nikoloski G, Langemeijer SM, Kuiper RP et al. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat. Genet.42(8), 665–667 (2010).
   PubMed Web of Science ®Google Scholar
• Ernst T, Chase AJ, Score J et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat. Genet.42(8), 722–726 (2010).
   PubMed Web of Science ®Google Scholar
• Makishima H, Jankowska AM, Tiu RV et al. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia24(10), 1799–1804 (2010).
   PubMed Web of Science ®Google Scholar
• Christiansen DH, Andersen MK, Pedersen-Bjergaard J. Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis. J. Clin. Oncol.19(5), 1405–1413 (2001).
   PubMed Web of Science ®Google Scholar
• Bowen D, Groves MJ, Burnett AK et al.TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. Leukemia23(1), 203–206 (2009).
   PubMed Web of Science ®Google Scholar
• Haferlach C, Dicker F, Herholz H, Schnittger S, Kern W, Haferlach T. Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype. Leukemia22(8), 1539–1541 (2008).
   PubMed Web of Science ®Google Scholar
• Jasek M, Gondek LP, Bejanyan N et al.TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p. Leukemia24(1), 216–219 (2010).
   PubMed Web of Science ®Google Scholar
• Gelsi-Boyer V, Trouplin V, Adelaide J et al. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br. J. Haematol.145(6), 788–800 (2009).
   PubMed Web of Science ®Google Scholar
• Boultwood J, Perry J, Pellagatti A et al. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. Leukemia24(5), 1062–1065 (2010).
   PubMed Web of Science ®Google Scholar
• Ley TJ, Mardis ER, Ding L et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature456(7218), 66–72 (2008).
   PubMed Web of Science ®Google Scholar
• Graubert TA, Shen D, Ding L et al. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nature Genetics44(1), 53–57 (2011).
   PubMed Web of Science ®Google Scholar
• Yoshida K, Sanada M, Shiraishi Y et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature478(7367), 64–69 (2011).
   PubMed Web of Science ®Google Scholar
• Ding L, Ley TJ, Larson DE et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature481(7382), 506–510 (2012).
   PubMed Web of Science ®Google Scholar
• Link DC, Schuettpelz LG, Shen D et al. Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML. JAMA305(15), 1568–1576 (2011).
   PubMed Web of Science ®Google Scholar
• Welch JS, Westervelt P, Ding L et al. Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. JAMA305(15), 1577–1584 (2011).
   PubMed Web of Science ®Google Scholar
• Campbell PJ, Yachida S, Mudie LJ et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature467(7319), 1109–1113 (2010).
   PubMed Web of Science ®Google Scholar
• Maher CA, Kumar-Sinha C, Cao X et al. Transcriptome sequencing to detect gene fusions in cancer. Nature458(7234), 97–101 (2009).
   PubMed Web of Science ®Google Scholar
• Stephens PJ, Greenman CD, Fu B et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell144(1), 27–40 (2011).
   PubMed Web of Science ®Google Scholar
• Roychowdhury S, Iyer MK, Robinson DR et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci. Transl. Med.3(111), 111ra121 (2011).
   PubMed Web of Science ®Google Scholar
• Ebert BL, Pretz J, Bosco J et al. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature451(7176), 335–339 (2008).
   PubMed Web of Science ®Google Scholar
• Yang X, Boehm JS, Salehi-Ashtiani K et al. A public genome-scale lentiviral expression library of human ORFs. Nat. Methods8(8), 659–661 (2011).
   PubMed Web of Science ®Google Scholar
• Hahn CK, Berchuck JE, Ross KN et al. Proteomic and genetic approaches identify Syk as an AML target. Cancer Cell16(4), 281–294 (2009).
   PubMed Web of Science ®Google Scholar
• Graubert T, Walter MJ. Genetics of myelodysplastic syndromes: new insights. Hematol. Am. Soc. Hematol. Educ. Program2011, 543–549 (2011).
   PubMedGoogle Scholar